← Browse by Condition
Medical Condition

relapsed or refractory lymphoma including enkl

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06966154 Phase 1, Phase 2
Recruiting

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL

Enrollment
68 pts
Location
China
Sponsor
Fudan University
View Trial →